Chemoinformaics analysis of 3-(2-Methylpropyl)-cyclohexene
| Molecular Weight | 138.254 | nRot | 2 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
| Exact Molecular Weight | 138.141 | nRing | 1 |
| Solubility: LogS | -4.771 | nHRing | 0 |
| Solubility: LogP | 4.518 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 28.7023 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.513 |
| Synth | 3.235 |
| Natural Product Likeliness | 1.424 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.295 |
| MDCK | 0.0000205 |
| BBB | 0.692 |
| PPB | 0.95676 |
| VDSS | 3.204 |
| FU | 0.0430303 |
| CYP1A2-inh | 0.931 |
| CYP1A2-sub | 0.768 |
| CYP2c19-inh | 0.59 |
| CYP2c19-sub | 0.815 |
| CYP2c9-inh | 0.559 |
| CYP2c9-sub | 0.886 |
| CYP2d6-inh | 0.07 |
| CYP2d6-sub | 0.38 |
| CYP3a4-inh | 0.504 |
| CYP3a4-sub | 0.215 |
| CL | 10.848 |
| T12 | 0.26 |
| hERG | 0.006 |
| Ames | 0.011 |
| ROA | 0.029 |
| SkinSen | 0.496 |
| Carcinogencity | 0.153 |
| EI | 0.99 |
| Respiratory | 0.097 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.928147 |